• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·RAINBOW.NS
Share

Rainbow Children's Medicare Limited Stocks

₹ 1339.9Last Updated 11.06.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

₹ 1.41B

₹ 1339.9
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rainbow Children's Medicare Limited is a leading Indian healthcare provider managing a network of multi-specialty hospitals dedicated to pediatric, obstetrics, and gynecology services. Its comprehensive child health offerings include general pediatrics, neonatology, various surgical disciplines, gastroenterology, hematology, oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, and psychiatric support. The company also delivers specialized care such as intensive care units, bone marrow and kidney transplants, cochlear implants, genetic and metabolic medicine, and therapeutic services like speech, language, and occupational therapy, alongside developmental and behavioral pediatrics. For women's health, Rainbow provides extensive obstetrics and gynecology services, including high-risk pregnancy management, painless delivery options, childbirth education, post-delivery support, well-woman check-ups, urogynecology, pre-pregnancy assessments, minimally invasive surgery, breast care, fetal medicine, and menopausal treatments. Furthermore, the company offers a full spectrum of fertility solutions, encompassing ovulation induction, various in-vitro fertilization techniques (such as ICSI and IMSI), intrauterine insemination, assisted hatching, cryopreservation, donor programs (sperm, oocyte, embryo), surgical sperm retrieval, and reproductive surgery. As of December 31, 2021, the company operated 14 hospitals and 3 clinics across 6 cities, providing a total of 1,500 beds. Established in 1998, its headquarters are situated in Hyderabad, India.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of RAINBOW.NS is 1552 and suggests 16% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.06.2026 01:34

Rally ahead of SpaceX debut: best day since April for S&P 500 and Nasdaq, oil down 5%

12.06.2026 01:01

SpaceX holds record IPO: Elon Musk's space company raises $75 billion

12.06.2026 00:55

Google discusses producing part of its new AI chip at Samsung factories. Is this a threat to TSMC?

12.06.2026 00:10

BofA raised its rating on Intel stock by two notches at once. What is the bank betting on?

11.06.2026 22:46

Trump canceled planned new strikes on Iran. Oil below $90 per barrel

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026